EXENS

Exosens is a high-technology group specializing in the innovation, development, manufacturing, and sale of electro-optical technologies for amplification, detection, and imaging. The company operates through two main segments: Amplification, which includes image intensifier tubes and portable optronics such as night vision binoculars and thermal sights, and Detection and Imaging, covering digital cameras across the electromagnetic spectrum from ultraviolet to longwave infrared, as well as detectors for ions, electrons, neutrons, and gamma rays. Exosens serves four primary markets: defense and surveillance, life sciences and environment, industrial control, and nuclear applications. The majority of its products are sold to original equipment manufacturers (OEMs) who integrate these components into their own systems, while a smaller portion is sold directly to end-users in sectors such as space and scientific research. The group markets its products under the brands Photonis, Xenics, Telops, and El-Mul, and has acquired companies including NVLS, Noxant, and Phasics. Exosens maintains production and R&D sites in France, the Netherlands, Belgium, the United States, Germany, the United Kingdom, and Canada, serving customers in multiple countries.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Electronic Components Homepage exosens.com
Sector Technology IR page exosens.com/investors
Tags
electro-optics, image intensifiers, infrared imaging, particle detection, nuclear instrumentation, night vision, defense technology, industrial inspection, scientific research, photonics, Photonis, Xenics, Telops, El-Mul, NVLS, Noxant, Phasics, Emberion
Press page —

Metrics

Valuation  
Market cap € 3.285B
Market cap (USD) $ 3.61B
P/E 108.97
PEG 1.29
P/BV 7.29
P/S 6.61
P/OCF 30.60
P/FCF 127.89
Dividend yield —
Turnover / mcap —
Returns  
ROE 10.0%
ROI 6.1%
ROIC 11.7%
Profit margin 9.1%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y —
Earnings growth 3y (net profit CAGR) 84.3%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 55.8%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 44
Quality score 25.0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue 468.187M 394.076M 291.819M 200.751M 166.168M
Net profit 42.715M 30.68M 18.407M 11.212M -148.965M
Free cash flow — — — 25.686M 42.655M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Share price 54 20.3 70.62 — —
Price performance 12m 1.66 -0.71 — — —

Filed figures

Figure Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (EUR) 69.2M 71M 73.1M
↳ YoY growth +2.6% +3.0%
Borrowings, current (EUR) 7.03M 2.45M 493,000
Borrowings, non-current (EUR) 301M 248M 249M
Lease liabilities (EUR) 10.1M 10.9M 16.6M
Cash and deposits (EUR) 15.5M 117M 68.6M
Intangible assets (EUR) 202M 205M 226M
Right-of-use assets (EUR) 10.8M 10.6M 15M
Net debt (borrowings + leases - cash) (EUR) 302M 144M 198M
Cash flow detail
Operating cash flow (EUR) 50.5M 96.3M 107M
Dividends paid (cash effect) (EUR) — 0.00 -5.08M
Income taxes paid (cash effect) (EUR) -6.87M -6.67M -18.6M
Share-based compensation (EUR) 1.6M 2.9M 5.7M
Income detail
Total comprehensive income (EUR) 19M 31.9M 36.5M
Comprehensive income to owners (EUR) 19M 31.9M 36.5M
Reported Apr 29, 2025 Mar 9, 2026 Mar 9, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Exosens (ticker EXENS), listed in France.

ETFs Holding Exosens

ETF Weight in ETF Shares Market value As of
AVDS 0.08% 5,363 $ 301.785K Nov 16, 2026
DFIS 0.04% 40,936 $ 2.369M Nov 12, 2026
DFAI 0.01% 26,119 $ 1.512M Nov 12, 2026
DFSI 0.01% 1,664 $ 96.308K Nov 12, 2026
DFIC 0.01% 18,771 $ 1.086M Nov 12, 2026
DFAX 0.00% 3,958 $ 229.08K Nov 12, 2026
AVDE 0.00% 1,818 $ 102.302K Nov 16, 2026